Cargando…
Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044391/ https://www.ncbi.nlm.nih.gov/pubmed/35477929 http://dx.doi.org/10.1038/s41392-022-01000-3 |
| _version_ | 1784695096071946240 |
|---|---|
| author | Popowicz, Grzegorz Maria Pyrc, Krzysztof Hadian, Kamyar |
| author_facet | Popowicz, Grzegorz Maria Pyrc, Krzysztof Hadian, Kamyar |
| author_sort | Popowicz, Grzegorz Maria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9044391 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90443912022-04-27 Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle Popowicz, Grzegorz Maria Pyrc, Krzysztof Hadian, Kamyar Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2022-04-27 /pmc/articles/PMC9044391/ /pubmed/35477929 http://dx.doi.org/10.1038/s41392-022-01000-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Highlight Popowicz, Grzegorz Maria Pyrc, Krzysztof Hadian, Kamyar Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle |
| title | Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle |
| title_full | Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle |
| title_fullStr | Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle |
| title_full_unstemmed | Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle |
| title_short | Vaccination versus SARS-CoV-2 Omicron: three vaccine doses win the battle |
| title_sort | vaccination versus sars-cov-2 omicron: three vaccine doses win the battle |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044391/ https://www.ncbi.nlm.nih.gov/pubmed/35477929 http://dx.doi.org/10.1038/s41392-022-01000-3 |
| work_keys_str_mv | AT popowiczgrzegorzmaria vaccinationversussarscov2omicronthreevaccinedoseswinthebattle AT pyrckrzysztof vaccinationversussarscov2omicronthreevaccinedoseswinthebattle AT hadiankamyar vaccinationversussarscov2omicronthreevaccinedoseswinthebattle |